TIMOLOL SOLUTION - 0.5% 0.5 %
TIMOLOL MALEATE : 0.5 % · DIN 02147483 · BDH INC.
Health Canada status: CANCELLED POST MARKET
What is TIMOLOL SOLUTION - 0.5%?
TIMOLOL SOLUTION - 0.5% 0.5 % contains TIMOLOL MALEATE : 0.5 %. It is listed in the Health Canada Drug Product Database under DIN 02147483, held by BDH INC., supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02147483 |
|---|---|
| Brand name | TIMOLOL SOLUTION - 0.5% |
| Generic / active ingredient | TIMOLOL MALEATE : 0.5 % |
| Manufacturer | BDH INC. |
| Strength | 0.5 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01ED01 TIMOLOL |
| AHFS class | 12:20.12 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2000 |
| Original market date | 1995-12-31 00:00:00 |
Is TIMOLOL in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01ED01 TIMOLOL. 7 of 35 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP-TIMOLOL | 0.5 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02447800 |
| SANDOZ TIMOLOL | 0.25 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02166712 |
| SANDOZ TIMOLOL | 0.5 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02166720 |
| TIMOLOL MALEATE-EX | 0.25 % | SOLUTION (EXTENDED RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02242275 |
| TIMOLOL MALEATE-EX | 0.5 % | SOLUTION (EXTENDED RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02242276 |
| TIMOPTIC | 0.5 % | SOLUTION | ELVIUM LIFE SCIENCES | MARKETED | DIN 00451207 |
| TIMOPTIC-XE | 0.5 % | SOLUTION (EXTENDED RELEASE) | ELVIUM LIFE SCIENCES | MARKETED | DIN 02171899 |
| APO-TIMOP | 0.25 % | SOLUTION | APOTEX INC | DORMANT | DIN 00755826 |
| APO-TIMOP | 0.5 % | SOLUTION | APOTEX INC | DORMANT | DIN 00755834 |
| APO-TIMOP GEL | 0.25 % | SOLUTION (EXTENDED RELEASE) | APOTEX INC | APPROVED | DIN 02315858 |
Who else supplies TIMOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TIMOLOL appears in 178 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.